AT
Andrea Tan Goldman Sachs Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Insmed
INSM
$30.1B
| $142.53 | $142 |
0%
downside
| Buy | 22 days ago |
|
2
Iovance Biotherapeutics
IOVA
$796M
| $2.20 | $8 |
264%
upside
| Buy | 3 months ago |
|
3
Tarsus Pharmaceuticals
TARS
$2.42B
| $57.43 | $51 |
11%
downside
| Neutral | 4 months ago |
|
4
Day One Biopharmaceuticals
DAWN
$759M
| $7.41 | $27 |
264%
upside
| Buy | 5 months ago |
|
5
Arrowhead Research
ARWR
$3.87B
| $28 | $31 |
11%
upside
| Neutral | 1 year ago |
|
6
Kodiak Sciences
KOD
$452M
| $8.55 | $2 |
77%
downside
| Sell | 1 year ago |
|
7
Krystal Biotech
KRYS
$4.33B
| $149.75 | $160 |
7%
upside
| Buy | 1 year ago |
|
8
AbCellera Biologics
ABCL
$1.24B
| $4.16 | $24 |
477%
upside
| Buy | 2 years ago |
|
9
Madrigal Pharmaceuticals
MDGL
$9.61B
| $431.21 | $375 |
13%
downside
| Buy | 2 years ago |
|